Literature DB >> 34919128

Vascular endothelial growth factor c regulates hematopoietic stem cell fate in the dorsal aorta.

Rebecca K Schiavo1, Owen J Tamplin1.   

Abstract

Hematopoietic stem and progenitor cells (HSPCs) are multipotent cells that self-renew or differentiate to establish the entire blood hierarchy. HSPCs arise from the hemogenic endothelium of the dorsal aorta (DA) during development in a process called endothelial-to-hematopoietic transition. The factors and signals that control HSPC fate decisions from the hemogenic endothelium are not fully understood. We found that Vegfc has a role in HSPC emergence from the zebrafish DA. Using time-lapse live imaging, we show that some HSPCs in the DA of vegfc loss-of-function embryos display altered cellular behavior. Instead of typical budding from the DA, emergent HSPCs exhibit crawling behavior similar to myeloid cells. This was confirmed by increased myeloid cell marker expression in the ventral wall of the DA and the caudal hematopoietic tissue. This increase in myeloid cells corresponded with a decrease in HSPCs that persisted into larval stages. Together, our data suggest that Vegfc regulates HSPC emergence in the hemogenic endothelium, in part by suppressing a myeloid cell fate. Our study provides a potential signal for modulation of HSPC fate in stem cell differentiation protocols.
© 2022. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Dorsal aorta; Hematopoiesis; Hematopoietic stem cells; Hemogenic endothelium; VEGFC; Zebrafish

Mesh:

Substances:

Year:  2022        PMID: 34919128      PMCID: PMC8917412          DOI: 10.1242/dev.199498

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  74 in total

1.  VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.

Authors:  K Hamada; Y Oike; N Takakura; Y Ito; L Jussila; D J Dumont; K Alitalo; T Suda
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  An improved method of staining leucocyte granules with Sudan black B.

Authors:  H L SHEEHAN; G W STOREY
Journal:  J Pathol Bacteriol       Date:  1947 Jan-Apr

3.  Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416.

Authors:  J Sukbuntherng; G Cropp; A Hannah; G S Wagner; L K Shawver; L Antonian
Journal:  J Pharm Pharmacol       Date:  2001-12       Impact factor: 3.765

4.  SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish.

Authors:  E C Liao; B H Paw; A C Oates; S J Pratt; J H Postlethwait; L I Zon
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

5.  Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish.

Authors:  G J Lieschke; A C Oates; M O Crowhurst; A C Ward; J E Layton
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

6.  Zebrafish angiogenesis: a new model for drug screening.

Authors:  G N Serbedzija; E Flynn; C E Willett
Journal:  Angiogenesis       Date:  1999       Impact factor: 9.596

7.  Haematopoietic stem cells derive directly from aortic endothelium during development.

Authors:  Julien Y Bertrand; Neil C Chi; Buyung Santoso; Shutian Teng; Didier Y R Stainier; David Traver
Journal:  Nature       Date:  2010-02-14       Impact factor: 49.962

8.  Vegfc is required for vascular development and endoderm morphogenesis in zebrafish.

Authors:  Elke A Ober; Birgitta Olofsson; Taija Mäkinen; Suk-Won Jin; Wataru Shoji; Gou Young Koh; Kari Alitalo; Didier Y R Stainier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

9.  Cbfa2 is required for the formation of intra-aortic hematopoietic clusters.

Authors:  T North; T L Gu; T Stacy; Q Wang; L Howard; M Binder; M Marín-Padilla; N A Speck
Journal:  Development       Date:  1999-06       Impact factor: 6.868

10.  The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish.

Authors:  Chris Hall; Maria Vega Flores; Thilo Storm; Kathy Crosier; Phil Crosier
Journal:  BMC Dev Biol       Date:  2007-05-04       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.